Matches in Nanopublications for { ?s ?p "[In this study, though only a single cell line was used for the experiment and the data are limited, our results suggest that paclitaxel together with low-dose CPT-11 is a promising basis for a new combination cancer chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP946889.RAWsKJ1cturjaNhP4rKwl6awP9EdYL08qI9nhkW_KmGLA130_assertion description "[In this study, though only a single cell line was used for the experiment and the data are limited, our results suggest that paclitaxel together with low-dose CPT-11 is a promising basis for a new combination cancer chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946889.RAWsKJ1cturjaNhP4rKwl6awP9EdYL08qI9nhkW_KmGLA130_provenance.
- NP947121.RAT5AqKdlxgkNyBjQcSsdfaKHIW66ep1lz-muapukdFLM130_assertion description "[In this study, though only a single cell line was used for the experiment and the data are limited, our results suggest that paclitaxel together with low-dose CPT-11 is a promising basis for a new combination cancer chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947121.RAT5AqKdlxgkNyBjQcSsdfaKHIW66ep1lz-muapukdFLM130_provenance.
- NP925808.RArMHz8NQf0IDqhiKE0d872piNqUK5AFbtonbG9p_pUk8130_assertion description "[In this study, though only a single cell line was used for the experiment and the data are limited, our results suggest that paclitaxel together with low-dose CPT-11 is a promising basis for a new combination cancer chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925808.RArMHz8NQf0IDqhiKE0d872piNqUK5AFbtonbG9p_pUk8130_provenance.
- NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_assertion description "[In this study, though only a single cell line was used for the experiment and the data are limited, our results suggest that paclitaxel together with low-dose CPT-11 is a promising basis for a new combination cancer chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_provenance.